Indoco Remedies Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies' promoters and promoter group members have filed a yearly disclosure confirming they did not create any encumbrance (pledge, lien, or charge) on their shareholding in the company during FY 2024-2025. The filing lists 16 individuals and entities classified as promoters, promoter group, or persons acting in concert. Two notable changes occurred during the year: Ms. Sudha Pai passed away on May 4, 2024 and ceased to be part of the promoter group, while Ms. Pooja Rajendra Pai was added to the promoter group through transmission of shares from Ms. Sudha Pai. The disclosure was signed by Suresh Kare on behalf of the entire promoter group and submitted to both NSE and BSE on April 7, 2025.
This is a routine yearly compliance filing with no direct stock price impact. The absence of any encumbrance (no pledging of promoter shares) is a mildly reassuring signal for retail investors, indicating promoters are not under financial stress requiring them to pledge their holdings. Shareholders should note the ownership change due to Ms. Sudha Pai's demise and the corresponding transmission of shares.